Related Experiment Videos
Inflammation in pulmonary arterial hypertension
P Dorfmüller1, F Perros, K Balabanian
1Centre for Pulmonary Vascular Diseases UPRES EA 2705, Dept of Respiratory and Intensive Care Medicine, South Paris Cytokine Institute, Antoine Béclère Hospital, Assistance Publique-Hôpitaux de Paris, South Paris University, Clamart, France.
The European Respiratory Journal
|September 4, 2003
Summary
Inflammation plays a key role in pulmonary hypertension (PH), particularly in pulmonary arterial hypertension (PAH). Understanding these inflammatory mechanisms is crucial for developing effective treatments for PH patients.
Area of Science:
- Pulmonary Medicine
- Immunology
- Pathophysiology
Background:
- Inflammatory mechanisms are implicated in various forms of pulmonary hypertension (PH).
- This includes monocrotaline-induced PH in rats and human pulmonary arterial hypertension (PAH) linked to connective tissue diseases, HIV, and POEMS syndrome.
- Improvements in some PAH patients with immunosuppressive therapy highlight inflammation's relevance.
Purpose of the Study:
- To investigate the role of inflammatory mechanisms in the pathophysiology of pulmonary hypertension.
- To explore immunological disturbances observed in primary pulmonary hypertension (PPH) patients.
Main Methods:
- Review of existing literature on inflammatory mechanisms in PH.
- Analysis of patient data including immunological markers and lung histology.
- Examination of circulating autoantibodies and pro-inflammatory cytokines (interleukins-1 and -6) in PPH patients.
- Histological assessment of inflammatory infiltrates and chemokine expression (RANTES, fractalkine) in PPH lung tissue.
Main Results:
- Patients with PAH associated with systemic lupus erythematosus show improvement with immunosuppressive therapy.
- Primary PH (PPH) patients exhibit immunological disturbances, including autoantibodies and elevated pro-inflammatory cytokines.
- Lung histology in severe PPH reveals inflammatory infiltrates and increased chemokine expression.
Conclusions:
- Inflammation is a significant factor in the pathophysiology of certain types of pulmonary hypertension.
- Further research is needed to fully elucidate the role of inflammation in PH and its potential as a therapeutic target.